Scout is a 7-year-old Border Collie whose noise phobia has escalated over three years from mild trembling during fireworks to destructive panic with self-injury — including a screen-window escape that put him in traffic. This course covers the full clinical spectrum: noise phobia vs. multi-sensory thunderstorm phobia, the neurobiology of fear from the thalamic fork through amygdala activation to the cortisol and norepinephrine cascades, the FDA-approved and off-label event-specific pharmacotherapy toolkit with doses calculated for a real patient, the critical case against acepromazine, systematic desensitization and counterconditioning as the curative treatment, and an integrative anti-anxiety toolkit from Thundershirts to acupuncture to CBD. Earn 1.0 RACE CE credit.
Opening case: Scout, a 7-year-old male neutered Border Collie with a 3-year history of escalating noise phobia. Physical evidence of fear-related self-injury — cracked and hemorrhagic nail beds, a healed thoracic laceration from a screen-window escape. Noise phobia vs. thunderstorm phobia distinction, comorbid generalized anxiety, breed predisposition, and the sensitization trajectory that makes untreated noise phobia a progressive emergency.
The auditory pathway from cochlea to thalamus; the thalamic fork — the low road (thalamo-amygdala, 12–15 ms, crude and fast) vs. the high road (thalamo-cortical-amygdala, 30–40 ms, detailed); lateral, basolateral, and central amygdala nuclei; the HPA axis cortisol cascade and locus coeruleus norepinephrine cascade; single-trial fear learning; conditioned vs. unconditioned fear responses; fear generalization; learned helplessness; memory reconsolidation as the neurobiological basis of desensitization.
10 questions · Passing score: 70%
Complete all course modules to unlock the assessment. Upon passing, your CE certificate will be generated automatically.
Event-specific medications: Sileo (dexmedetomidine oromucosal gel — FDA-approved, alpha-2 agonist, dose and administration technique); trazodone (SARI, dose calculated for Scout at 19 kg); alprazolam (benzodiazepine, paradoxical excitation risk in herding breeds); gabapentin (calcium channel modulator, xylitol warning); acepromazine and why it produces sedation without anxiolysis — the ACVB/AVSAB position. Daily maintenance: fluoxetine, sertraline, clonidine. Combination protocols for mild, moderate, and severe cases.
The curative treatment and memory reconsolidation mechanism; building the stimulus hierarchy; identifying the sub-threshold baseline; counterconditioning mechanics — timing, consistency, reinforcer quality; safe space design with interior room selection, white noise, Adaptil diffuser, and blackout curtains; storm prediction apps and preemptive medication timing; why flooding is contraindicated; videography for behavioral assessment and treatment monitoring.
Thundershirt (deep pressure therapy — evidence, limitations, and trial protocol); Adaptil DAP — collar, diffuser, and spray deployment strategy; melatonin (xylitol warning); L-theanine (Anxitane) mechanism and dose for Scout; alpha-casozepine (Zylkene) GABA-A modulation and seasonal pre-loading; Storm Defender Cape and the anti-static hypothesis; Through a Dog's Ear species-specific music; CBD evidence, CYP2D6 interaction with fluoxetine, and COA verification; acupuncture points GV20, HT7, ear Shenmen, and An Mian with electroacupuncture protocol.
Scout's complete 6-tier treatment plan; the 6-week recheck — generalized anxiety improving, early desensitization progress, reduced but managed storm response with no self-injury; the Fourth of July detailed protocol — timed medication schedule, safe space activation, DO NOT instructions; post-July 4th owner report and clinical interpretation; long-term seasonal intensification vs. off-season management; when and how to taper fluoxetine after 12–18 months; desensitization as the curative, long-term investment.